Phenominer Database Results (29 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 14 3.93 null 0.17 0.64 necropsy 0 DMBA oral gavage 0 necropsy 11341 73
COP/CrCrl mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 7 0.1 null 0.15 0.4 necropsy 0 11370 75
WF.COP-(D2Mit29-D2Rat201)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 19 1.5 null 0.3 1.31 necropsy 0.0 0 3X3 mm diameter or larger 70168 143
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.86 null 0.7 2.63 necropsy 0 DMBA oral gavage 105 days necropsy 65573 86
ACI.COP-(D10Mgh8-D10Rat4)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11365 75
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 29 6.3 null 0.5 2.69 necropsy 0.0 0 3X3 mm diameter or larger 70167 143
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 48 11.23 null 0.07 0.51 necropsy 0 DMBA oral gavage 0 necropsy 11340 73
COP/CrCrl mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 5 0.0 null necropsy 0 11369 75
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 30 8.1 null 0.7 3.83 necropsy 0 3X3 mm diameter or larger 11746 143
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 46 7.61 null 0.07 0.45 necropsy 0 DMBA oral gavage 0 necropsy 11342 73
ACI.COP-(D3Mgh16-D3Rat119)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11361 75
ACI.COP-(D3Rat130-D3Rat114)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11363 75
ACI/SegHsd mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 4 0.0 null necropsy 0 11367 75
SS-Chr 13BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 5.33 null 1.21 4.38 necropsy 0 DMBA oral gavage 105 days necropsy 11501 86
SS-Chr 16BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 6.31 null 1.61 5.79 necropsy 0 DMBA oral gavage 105 days necropsy 11504 86
WF mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days) Shepel LA, et al., Genetics 1998 May;149(1):289-99 mammary gland integrity trait female 181 days-200 days 53 3.62 null 0.27 1.95 necropsy 0.0 DMBA oral gavage 126 days from 126 to 140 days 66100 689
SS-Chr 19BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 8.79 null 1.25 4.68 necropsy 0 DMBA oral gavage 105 days necropsy 11507 86
ACI.COP-(D3Mgh16-D3Rat119)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 8 4.3 null 1.13 3.2 necropsy 0 11362 75
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 99 and 197 days) Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601 mammary gland integrity trait female 160 days-260 days 20 5.6 null necropsy 0.0 0 tumor size reach 1-1.5 cm 11377 76
WKY/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Lan H, et al., Genetics 2001 Jan;157(1):331-9 mammary gland integrity trait female 169 days-174 days 17 0.0 null necropsy 0 3X3 mm diameter or larger 11741 141
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Lan H, et al., Genetics 2001 Jan;157(1):331-9 mammary gland integrity trait female 169 days-174 days 21 7.3 null 0.98 4.5 necropsy 0 3X3 mm diameter or larger 11742 141
COP/OlaHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 16 0.25 null 0.1 0.4 necropsy 0 3X3 mm diameter or larger 11747 143
ACI.COP-(D6Rat80-D6Rat146)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11359 75
SS.BN-(D6Rat149-D6Arb3)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.77 null 0.64 2.39 necropsy 0 DMBA oral gavage 105 days necropsy 65571 86
ACI.COP-(D6Rat80-D6Rat146)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 17 2.4 null 0.41 1.7 necropsy 0 11360 75
ACI.COP-(D3Rat130-D3Rat114)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 17 4.5 null 0.73 3.0 necropsy 0 11364 75
ACI.COP-(D10Mgh8-D10Rat4)/Shul mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 12 4.8 null 1.04 3.6 necropsy 0 11366 75
SS/JrHsdMcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 2.45 null 0.21 1.32 necropsy 0 DMBA oral gavage 105 days necropsy 11488 86
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (for 196 days) Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 21 7.0 null 1.16 5.3 necropsy 0 11368 75